Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2023

Revenue Recognition

Schedule of disaggregation of revenues by payer types

	Three months ended
	March 31,
	2023		2022
(in thousands)
Insurance carriers	$	210,378	$	164,742
Laboratory and other partners		22,805		20,737
Patients		8,573		8,654
Total revenues	$	241,756	$	194,133

Schedule of total revenue by geographic area

	Three months ended
	March 31,
	2023		2022
(in thousands)
United States	$	233,254	$	187,217
Americas, excluding U.S.		1,158		741
Europe, Middle East, India, Africa		5,196		3,691
Asia Pacific and Other		2,148		2,484
Total revenues	$	241,756	$	194,133

Schedule of beginning and ending balances of accounts receivable and deferred revenues

	Balance at		Balance at
	March 31,		December 31,
(in thousands)	2023		2022
Assets:
Accounts receivable, net	$	246,785	$	244,385
Liabilities:
Deferred revenue, current portion	$	16,579	$	10,777
Deferred revenue, long-term portion		21,511		20,001
Total deferred revenues	$	38,090	$	30,778

Schedule of changes in the balance of deferred revenues

	March 31,			March 31,
	2023			2022
(in thousands)
Beginning balance	$	30,778	$	28,722
Increase in deferred revenues		12,100		10,508
Revenue recognized during the period that was included in deferred revenues at the beginning of the period		(3,988)		(3,889)
Revenue recognized from performance obligations satisfied within the same period		(800)		(884)
Ending balance	$	38,090	$	34,457